(Q47403340)

15 January 2018

title

In vitro inhibition of fibrinolysis by apolipoprotein(a) and lipoprotein(a) is size- and concentration-dependent (English)

1 reference

15 January 2018

author name string

Jean-Pierre Knapp

series ordinal

1

1 reference

15 January 2018

Wolfgang Herrmann

series ordinal

2

1 reference

15 January 2018

publication date

1 January 2004

1 reference

15 January 2018

Clinical Chemistry and Laboratory Medicine

published in

1 reference

15 January 2018

volume

42

1 reference

15 January 2018

issue

9

1 reference

15 January 2018

page(s)

1013-1019

1 reference

15 January 2018

Apolipoprotein(a) phenotypes as genetic markers of coronary atherosclerosis severity

cites work

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2004.205

Kringle-containing fragments of apolipoprotein(a) circulate in human plasma and are excreted into the urine

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2004.205

The relative electrophoretic mobility of apo(a) isoforms depends on the gel system: proposal of a nomenclature for apo(a) phenotypes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2004.205

Atherogenesis in transgenic mice expressing human apolipoprotein(a)

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2004.205

Lipoprotein(a) vascular accumulation in mice. In vivo analysis of the role of lysine binding sites using recombinant adenovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2004.205

Lipoprotein cholesterol, apolipoprotein A-I and B and lipoprotein (a) abnormalities in men with premature coronary artery disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2004.205

Plasma Lp(a), apolipoprotein(a) isoforms and acute myocardial infarction in men and women: a case-control study in the Jerusalem population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2004.205

Apolipoprotein(a) kringle 4-containing fragments in human urine. Relationship to plasma levels of lipoprotein(a).

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2004.205

Polymorphonuclear cells isolated from human peripheral blood cleave lipoprotein(a) and apolipoprotein(a) at multiple interkringle sites via the enzyme elastase. Generation of mini-Lp(a) particles and apo(a) fragments

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2004.205

A prospective case-control study of lipoprotein(a) levels and apo(a) size and risk of coronary heart disease in Stanford Five-City Project participants

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2004.205

Lp(a) particles mold fibrin-binding properties of apo(a) in size-dependent manner: a study with different-length recombinant apo(a), native Lp(a), and monoclonal antibody.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2004.205

Lipoprotein(a): structural implications for pathophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2004.205

Association of levels of lipoprotein Lp(a), plasma lipids, and other lipoproteins with coronary artery disease documented by angiography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2004.205

Urinary apo(a) discriminates coronary artery disease patients from controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2004.205

Urinary Excretion of Apo(a) Fragments

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2004.205

21 January 2018

Identifiers

DOI

10.1515/CCLM.2004.205

1 reference

15 January 2018

1 reference

15 January 2018